Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses. (Q39034922)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 February 2015

Language	Label	Description	Also known as
English	Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses.	scientific article published on 26 February 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

0 references

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

author name string

P Mitchell

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

N Thatcher

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

M A Socinski

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

E Wasilewska-Tesluk

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

K Horwood

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

A Szczesna

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

C Martín

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

M Zukin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

C Helwig

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

M Falk

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

C Butts

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

F A Shepherd

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

1134-1142

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382 AND SRC:MED&resulttype=core&format=json

1 March 2020

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV104

21 January 2018

Is consolidation chemotherapy after concurrent chemo-radiotherapy beneficial for patients with locally advanced non-small-cell lung cancer? A pooled analysis of the literature

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV104

21 January 2018

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV104

21 January 2018

MUC1 as a target antigen for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV104

21 January 2018

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV104

21 January 2018

Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV104

21 January 2018

Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV104

21 January 2018

Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV104

21 January 2018

Antitumor effects of L-BLP25 antigen-specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV104

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39034922&oldid=1636083263"